Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AZIYO BIOLOGICS, INC. (AZYO)
|
|
| Segments |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues |
| Cardiovascular | 1.7 | 1.7 | | | 2.1 | 1.6 | | |
| Device Protection | 2.2 | 2.4 | | | 2.2 | 2.1 | | |
| Women's Health | 2.4 | 2.3 | | | 1.8 | 1.6 | | |
| Orthobiologics | 3.9 | 6.7 | | | 6.5 | 6.2 | | |
| Non-Core Products | | | | 3.4 | | | | 2.9 |
| Core Products | | | | 8.9 | | | | 8.6 |
| |
| Mix |
| Cardiovascular | 16.8% | 13.4% | | | 16.6% | 13.6% | | |
| Device Protection | 21.6% | 18.0% | | | 17.8% | 17.9% | | |
| Women's Health | 23.3% | 17.6% | | | 14.4% | 14.2% | | |
| Orthobiologics | 38.3% | 51.0% | | | 51.2% | 54.3% | | |
| Non-Core Products | | | | 27.8% | | | | 25.2% |
| Core Products | | | | 72.2% | | | | 74.8% |
| |
| Growth |
| Cardiovascular | -17.4% | 11.6% | | | | | | |
| Device Protection | -1.0% | 14.5% | | | | | | |
| Women's Health | 31.6% | 40.5% | | | | | | |
| Orthobiologics | -39.1% | 6.6% | | | | | | |
| Non-Core Products | | | | 18.7% | | | | 102.7% |
| Core Products | | | | 4.2% | | | | -17.0% |
|